Boston Scientific Corporation (BSX)
NYSE: BSX · IEX Real-Time Price · USD
76.55
+0.14 (0.18%)
At close: Jul 2, 2024, 4:00 PM
76.03
-0.52 (-0.68%)
After-hours: Jul 2, 2024, 7:50 PM EDT
Boston Scientific Stock Forecast
Stock Price Forecast
The 22 analysts with 12-month price forecasts for Boston Scientific stock have an average target of 77.41, with a low estimate of 60 and a high estimate of 95. The average target predicts an increase of 1.12% from the current stock price of 76.55.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BSX stock from 22 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 10 | 10 | 11 | 12 | 12 | 11 |
Buy | 10 | 10 | 10 | 9 | 9 | 9 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 22 | 22 | 23 | 23 | 23 | 22 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Evercore ISI Group | Evercore ISI Group | Buy Maintains $78 → $81 | Buy | Maintains | $78 → $81 | +5.81% | Jul 2, 2024 |
Needham | Needham | Strong Buy Reiterates $82 | Strong Buy | Reiterates | $82 | +7.12% | Jun 18, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Initiates $90 | Strong Buy | Initiates | $90 | +17.57% | May 30, 2024 |
Argus Research | Argus Research | Strong Buy Maintains $80 → $95 | Strong Buy | Maintains | $80 → $95 | +24.10% | May 28, 2024 |
Citigroup | Citigroup | Strong Buy Maintains $85 → $87 | Strong Buy | Maintains | $85 → $87 | +13.65% | May 22, 2024 |
Financial Forecast
Revenue This Year
16.16B
from 14.24B
Increased by 13.48%
Revenue Next Year
17.80B
from 16.16B
Increased by 10.13%
EPS This Year
2.35
from 1.07
Increased by 120.08%
EPS Next Year
2.67
from 2.35
Increased by 13.48%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 17.1B | 19.0B | 20.8B | 22.1B | 24.0B |
Avg | 16.2B | 17.8B | 19.5B | 21.0B | 22.8B |
Low | 15.5B | 16.9B | 17.9B | 19.9B | 21.8B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 19.8% | 17.5% | 16.7% | 13.3% | 14.5% |
Avg | 13.5% | 10.1% | 9.5% | 7.6% | 8.7% |
Low | 9.0% | 4.4% | 0.7% | 2.3% | 3.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.53 | 2.93 | 3.36 | 3.65 | 4.21 |
Avg | 2.35 | 2.67 | 3.02 | 3.35 | 3.76 |
Low | 2.25 | 2.50 | 2.79 | 3.15 | 3.52 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 136.5% | 24.4% | 25.7% | 21.0% | 25.8% |
Avg | 120.1% | 13.5% | 13.0% | 10.9% | 12.2% |
Low | 110.7% | 6.1% | 4.5% | 4.2% | 5.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.